Sex-specific Differences in the Stress Response to Abdominal Aortic Aneurysm Repair
SSStressAAA
Examination of Sex-specific Differences in the Stress Response to Abdominal Aortic Aneurysm Repair - A Prospective Cohort Study
1 other identifier
observational
60
1 country
1
Brief Summary
It is recognised that women are at greater risk of death, complications and longer hospital stay following intact abdominal aortic aneurysm (AAA) repair, and the reason for this is not yet established. This disparity in outcomes for women compared to men is also recognised in other forms of cardiovascular surgery, which raises the question of whether women and men are reacting differently to the stress of operative repair. This study aims to examine whether there are differences baseline stress markers and in the stress response to AAA repair between men and women. It will also examine whether markers of stress are associated with poor clinical outcomes and slower recovery (indicated by longer hospital stay). The study will take the form of an observational cohort study. It will not alter any of the treatment that men and women receive, but will monitor their stress levels using physiological markers (through ECG (electrocardiogram) monitoring using a non-invasive holter, biochemical markers using blood samples (which will be taken at the same time as routine testing, so as not to require further invasive procedures), and psychological testing, using short forms that the patient will be able to fill out independently at different stages of their recovery. Clinical data will be used to look for relevant factors (clinical history or medications) which may alter the stress markers we are observing, and to compare outcomes with markers of stress. Patients will be asked for their consent to share their data with the research team in order to participate in the study. It will be made clear that there will be no change in their clinical or operative management if they participate in the study and they will be able to withdraw consent for further participation at any time.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Feb 2022
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 18, 2022
CompletedStudy Start
First participant enrolled
February 1, 2022
CompletedFirst Posted
Study publicly available on registry
February 8, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 1, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
October 1, 2023
CompletedFebruary 8, 2022
January 1, 2022
1.7 years
January 18, 2022
January 28, 2022
Conditions
Outcome Measures
Primary Outcomes (1)
Biochemical measures of stress: level of serum cortisol & dehydroepiandrosterone (DHEA)
Sex-specific differences in baseline and timing/magnitude of response to operative stress.
Samples taken on the morning of operation (baseline), at anaesthetic induction, at the end of the procedure, 6 hours post-procedure and early morning samples during the remaining inpatient stay.
Secondary Outcomes (2)
Physiological parameters: assessment of beat-to-beat heart rate variability metrics.
Baseline recording compared to post-operative recording of patient recovery during inpatient stay.
Psychological measures of stress: measured by State Trait Anxiety Inventory-Y and self assessment (Likert Scale).
Pre-operative assessment compared to post-operative assessment at specified intervals during operative recovery - 2, 14, 30 and 90 days post-operation.
Study Arms (2)
Men
Elective AAA Repair
Women
Elective AAA Repair
Interventions
Eligibility Criteria
Men and women undergoing primary elective intact AAA repair, open or endovascular (EVAR) at participating centres. Consecutive recruitment.
You may qualify if:
- Men and women undergoing primary elective intact AAA repair, open or endovascular (EVAR) at participating centres.
- Capacity to consent.
You may not qualify if:
- Participants undergoing a secondary or emergency aortic procedure, or procedure for alternative aortic pathology.
- Relevant confounding pathology such as hypothalamic-pituitary axis pathology (e.g. Addison's disease).
- Lack of capacity to consent.
- Participants with pacemaker dependency, or a significant arrhythmia, will be excluded from analysis of heart rate variability, but will be included in the study for analysis of psychological and biochemical markers of stress.
- Participants on steroid treatment will also be excluded from analysis of biochemical markers but may be included for analysis of physiological markers and/or heart rate variability.
- Participants must be over the age of 50 (In order to facilitate capture of degenerative aortic aneurysmal pathology rather than an alternative aortic pathology e.g. traumatic, connective tissue disorder).
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Imperial College London
London, United Kingdom
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
January 18, 2022
First Posted
February 8, 2022
Study Start
February 1, 2022
Primary Completion
October 1, 2023
Study Completion
October 1, 2023
Last Updated
February 8, 2022
Record last verified: 2022-01